TGFB1 and Alzheimer disease: Thus, the beneficial improvement of AD manifestations in rats by memantine-rosuvastatin combination could be attributed to the effect of both drugs on dampening of the TGF-β1 signaling pathway, which operates a downstream cascade to modulate neuronal integrity.